Monroe Capital backs therapeutic products company

The $20 million loan will aid in the growth of the private equity sponsored Cytovance Biologics.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this